Publication highlights Deramiocel’s anti-fibrotic activity and describes a validated potency assay supporting quality control and product ...

Continued clinical execution of oncology strategy with focus on two pan-tumor programs, including combination approaches to address the full ...

Q3 2025 Earnings Call November 3, 2025 4:30 PM ESTCompany ParticipantsRobert DeVitaDavid Hung - Founder, President, CEO ...

There is no treatment approved for RSV, an important disease for infants and children in early life, as well as for geriatric ...

The $93.7 million increase was primarily driven by higher SG&A expenses related to spending on Vanda's commercial products as ...

Justice Samuel Alito has a financial stake in a pending Supreme Court case that could have far-reaching implications on ...

Even if the Supreme Court strikes down Donald Trump’s tariffs on countries, he has other legal options to impose similar ...

This football season, Teva is increasing education around tardive dyskinesia (TD) by launching ‘The Other TD’ campaign; TD is a chronic movement disorder impacting one in four ...

Developed by Ascentage Pharma, lisaftoclax is an orally available Bcl-2 inhibitor. Early data from the studies have demonstrated effects on hematologic malignancies and solid tumors. Lisaftoclax is ...

Developed by Ascentage Pharma, olverembatinib is the first China-approved third-generation BCR-ABL inhibitor, currently being jointly commercialized in China by Ascentage Pharma and Innovent Biologics ...

John Colaizzi, group VP, head of enterprise pharmacy practice at Walgreens, shared the findings of a recent study that explored pharmacy technicians' interest in pursuing a PharmD degree.